Novel role of MDA-9/Syntenin in regulating urothelial cell proliferation by modulating EGFR signaling

Clinical Cancer Research

Volumn 19, Issue 17, 2013, Pages 4621-4633

  Dasgupta, Santanu ^a,b   Menezes, Mitchell E ^a   Das, Swadesh K ^a   Emdad, Luni ^a,b   Janjic, Aleksandar ^a   Bhatia, Shilpa ^a   Mukhopadhyay, Nitai D ^a   Shao, Chunbo ^c   Sarkar, Devanand ^a,b   Fisher, Paul B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CLAUDIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE P60; PROTEIN ZO1; SYNTENIN; T CELL FACTOR 4; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MDA 9 GENE; METASTASIS; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; UROTHELIUM; UROTHELIUM CELL;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASMS; PROMOTER REGIONS, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SYNTENINS; UROTHELIUM;

EID: 84883317387     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-0585     Document Type: Article

References (33)

1. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25:285-95.
2. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come. CA Cancer J Clin 2010;60:244.
3. National Cancer Institute; 2013 [accessed 2013 Jun 21]. Available from: www.cancer.gov.
4. Proctor I, Stoeber K, Williams GH. Biomarkers in bladder cancer. Histopathology 2010;57:1-13.
5. Habuchi T, Marberger M, Droller MJ, Hemstreet GP III, Grossman HB, Schalken JA, et al. Prognostic markers for bladder cancer: international consensus panel on bladder cancer markers. Urology 2005;66:64-74. (Pubitemid 43049609)
6. McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009;28:335-44.
7. Sarkar D, Boukerche H, Su ZZ, Fisher PB. mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene. Pharmacol Ther 2004;104:101-15. (Pubitemid 39429466)
8. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, et al. mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res 2005;65:10901 -11.
9. Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB. mda-9/ Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB. Cancer Res 2007;67:1812-22. (Pubitemid 46383408)
10. Sarkar D, Boukerche H, Su ZZ, Fisher PB. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res 2008;68:3087-93.
11. Boukerche H, Aissaoui H, Prévost C, Hirbec H, Das SK, Su ZZ, et al. Src kinase activation is mandatory for MDA-9/synteninmediated activation of nuclear factor-kappaB. Oncogene 2010;29:3054 - 66.
12. Das SK, Bhutia SK, Kegelman TP, Peachy L, Oyesanya RA, Dasgupta S, et al. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front Biosci 2012;17:1-15.
13. Das SK, Bhuttia SK, Sokhi UK, Azab B, Su ZZ, Boukerche H, et al. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma. Cancer Res 2012;72:6217-26.
14. Das SK, Bhuttia SK, Azab B, Kegelman TP, Peachy L, Santhekadur PK, et al. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma. Cancer Res 2013;73:844-54.
15. Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, et al. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS ONE 2012;7:e29989.
16. Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW Jr, Chatterjee SK. Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells. J Cell Biochem 2006;97:1036-51.
17. Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Can Res 2008;68:700-6. (Pubitemid 351206745)
18. Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Forced cytochrome B gene mutation expression induces mitochondrial proliferation and prevents apoptosis in human uroepithelial SV-HUC-1 cells. Int J Cancer 2009;125:2829-35.
19. Boukerche H, Su ZZ, Prevot C, Sarkar D, Fisher PB. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src. Proc Natl Acad Sci U S A 2008;105:15914-9.
20. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31. (Pubitemid 35414532)
21. Hwangbo C, Park J, Lee JH. mda-9/Syntenin protein positively regulates the activation of Akt protein by facilitating integrin-linked kinase adaptor function during adhesion to type I collagen. J Biol Chem 2011;286:33601-12.
22. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 1999;274:8335-43.
23. Hu T, Li C. Convergence between Wnt-β-catenin and EGFR signaling in cancer. Mol Cancer 2010;9:236-43.
24. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, et al. Nuclear PKM2 regulates b-catenin transactivation upon EGFR activation. Nature 2011;480:118-22.
25. Zimmermann P, Tomatis D, Marcela R, Grootjans J, Leenaerts I, Degeest G, et al. Characterization of syntenin, a syndecan-binding PDZ protein as a component of cell adhesion sites and microfilaments. Mol Biol Cell 2001;12:339-50. (Pubitemid 33051579)
26. Yang LH, Xu HT, Han Y, Li QC, Liu Y, Zhao Y, et al. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells. Mol Cancer 2010;9:25-39.
27. Angus-Hill ML, Elbert KM, Hidalgo J, Capecchi MR. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc Natl Acad Sci U S A 2011;108:4914-9.
28. Singh AB, Sharma A, Dhawan P. Claudin family of proteins and cancer: an overview. J Oncology 2010;2010:541957.
29. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
30. Kusinska RU, Kordek R, Pluciennik E, Bednarek AK, Piekarski JH, Potemski P. Does vimentin help to delineate the so-called 'basal type breast cancer'? J Exp Clin Can Res 2009:28:118-27.
31. Chan AOO. E-cadherin in gastric cancer. World J Gastroenterol 2006;12:199-203. (Pubitemid 43336917)
32. Martinez-Estrada OM, Culleres A, Soriano FX, Peinado H, Bolos V, Martinez FO, et al. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J 2006;394:449-57. (Pubitemid 43342545)
33. Maret D, Gruzglin E, Sadr MS, Siu V, Shan W, Koch AW, et al. Surface expression of precursor N-cadherin promotes tumor cell invasion. Neoplasia 2010;12:1066-80.